The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-45
SponsorPsychiatric Research Unit, Region Zealand, Denmark
About this trial
The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.
Eligibility criteria
Qualifiers
Have had PPCS for a minimum of six months and a maximum of 18 months at the start of the study.
Being between 20 and 45 years of age
Disqualifiers
Elite athletes, as well as people who in general is physical active, at an intensity of moderat to high, for more than ten hours a week on average.
Participation in other interventions/treatment that could affect this study
=<6 months
=>18 months
Trial design
Treatments tested in this trial
- Creatine Monohydrate
Treatment groups
45 Participants
are divided into 3 treatment groupsSponsors and collaborators
Psychiatric Research Unit, Region Zealand, Denmark
Lead sponsor
University of Southern Denmark
Collaborator
Source ClinicalTrials.gov